149 related articles for article (PubMed ID: 31291281)
1. Model-based prediction of CD4 cells counts in HIV-infected adults on antiretroviral therapy in Northwest Ethiopia: A flexible mixed effects approach.
Awoke Ayele T; Worku A; Kebede Y; Zuma K; Kasim A; Shkedy Z
PLoS One; 2019; 14(7):e0218514. PubMed ID: 31291281
[TBL] [Abstract][Full Text] [Related]
2. Modeling Outcomes of First-Line Antiretroviral Therapy and Rate of CD4 Counts Change among a Cohort of HIV/AIDS Patients in Ethiopia: A Retrospective Cohort Study.
Awoke T; Worku A; Kebede Y; Kasim A; Birlie B; Braekers R; Zuma K; Shkedy Z
PLoS One; 2016; 11(12):e0168323. PubMed ID: 27997931
[TBL] [Abstract][Full Text] [Related]
3. Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: multilevel analysis.
Gezie LD
BMC Res Notes; 2016 Jul; 9():377. PubMed ID: 27475982
[TBL] [Abstract][Full Text] [Related]
4. The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART.
van Leth F; Andrews S; Grinsztejn B; Wilkins E; Lazanas MK; Lange JM; Montaner J;
AIDS; 2005 Mar; 19(5):463-71. PubMed ID: 15764851
[TBL] [Abstract][Full Text] [Related]
5. Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).
Seyoum A; Ndlovu P; Temesgen Z
AIDS Res Ther; 2017 Mar; 14(1):14. PubMed ID: 28302125
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia.
Ayele G; Tessema B; Amsalu A; Ferede G; Yismaw G
BMC Immunol; 2018 Dec; 19(1):37. PubMed ID: 30558580
[TBL] [Abstract][Full Text] [Related]
7. Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.
Hermans SM; Manabe YC; Kiragga AN; Hoepelman AI; Lange JM; van Leth F
Antivir Ther; 2013; 18(4):615-22. PubMed ID: 23423604
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children.
Lapphra K; Vanprapar N; Chearskul S; Phongsamart W; Chearskul P; Prasitsuebsai W; Chokephaibulkit K
Int J Infect Dis; 2008 Nov; 12(6):e33-8. PubMed ID: 18573672
[TBL] [Abstract][Full Text] [Related]
9. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
[TBL] [Abstract][Full Text] [Related]
10. Immunological recovery, failure and factors associated with CD-4 T-cells progression over time, among adolescents and adults living with HIV on Antiretroviral Therapy in Northern Ethiopia: A retrospective cross sectional study.
Desta AA; Wubayehu Woldearegay T; Berhe AA; Futwi N; Gebremedhn Gebru G; Godefay H
PLoS One; 2019; 14(12):e0226293. PubMed ID: 31830095
[TBL] [Abstract][Full Text] [Related]
11. Predictors of treatment failure on second-line antiretroviral therapy among adults in northwest Ethiopia: a multicentre retrospective follow-up study.
Tsegaye AT; Wubshet M; Awoke T; Addis Alene K
BMJ Open; 2016 Dec; 6(12):e012537. PubMed ID: 27932339
[TBL] [Abstract][Full Text] [Related]
12. Multilevel model on longitudinal data analysis in determinants of CD4 cell count among antiretroviral therapy attendant of HIV infected adults follow up in Gondar Teaching Referral Hospital, Gonder, Ethiopia.
Kebede K
AIDS Res Ther; 2021 Jan; 18(1):5. PubMed ID: 33451347
[TBL] [Abstract][Full Text] [Related]
13. Immunological Response of Hiv-Infected Children to Highly Active Antiretoviral Therapy at Gondar University Hospital, North-Western Ethiopia.
Kokeb M; Degu G
Ethiop J Health Sci; 2016 Jan; 26(1):25-30. PubMed ID: 26949313
[TBL] [Abstract][Full Text] [Related]
14. Nevirapine- versus efavirenz-based highly active antiretroviral therapy regimens in antiretroviral-naïve patients with advanced HIV infection.
Manosuthi W; Sungkanuparph S; Vibhagool A; Rattanasiri S; Thakkinstian A
HIV Med; 2004 Mar; 5(2):105-9. PubMed ID: 15012650
[TBL] [Abstract][Full Text] [Related]
15. Incidence and predictors of treatment failure among children on first-line antiretroviral therapy in Amhara Region Referral Hospitals, northwest Ethiopia 2018: A retrospective study.
Yihun BA; Kibret GD; Leshargie CT
PLoS One; 2019; 14(5):e0215300. PubMed ID: 31042743
[TBL] [Abstract][Full Text] [Related]
16. Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: the IMMUNEF clinical trial.
Soria A; Trabattoni D; Squillace N; Rainone V; Gnudi F; Clerici M; Gori A; Bandera A
PLoS One; 2015; 10(2):e0117118. PubMed ID: 25671649
[TBL] [Abstract][Full Text] [Related]
17. Impact of Age and Sex on CD4+ Cell Count Trajectories following Treatment Initiation: An Analysis of the Tanzanian HIV Treatment Database.
Means AR; Risher KA; Ujeneza EL; Maposa I; Nondi J; Bellan SE
PLoS One; 2016; 11(10):e0164148. PubMed ID: 27716818
[TBL] [Abstract][Full Text] [Related]
18. Different Degrees of Immune Recovery Using Antiretroviral Regimens with Vonavir or Zidovudine/Lamivudine/Efavirenz in HIVPositive Patients Receiving First Line Treatment in Iran.
Sadeghi L; Moallemi S; Tabatabai RA; Esmaeilzadeh A; Ahsani-Nasab S; Ahmadi NE; Bayanolhagh S; Lolaie M; Narouei A; SeyedAlinaghi S; Mohraz M
Infect Disord Drug Targets; 2018; 18(3):207-213. PubMed ID: 29308748
[TBL] [Abstract][Full Text] [Related]
19. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O
Cochrane Database Syst Rev; 2013 Jun; (6):CD008270. PubMed ID: 23740608
[TBL] [Abstract][Full Text] [Related]
20. Immunological outcomes of Tenofovir versus Zidovudine-based regimens among people living with HIV/AIDS: a two years retrospective cohort study.
Ayele T; Jarso H; Mamo G
AIDS Res Ther; 2017 Feb; 14(1):5. PubMed ID: 28143541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
